1.
To Evaluate the Effectiveness of Dpp4 Inhibitors in Relation to Blood Sugar and Lipid Profile. IJPHRD [Internet]. 2022 Jun. 24 [cited 2026 Jun. 17];13(3):175-9. Available from: https://mail.medicopublication.com/index.php/ijphrd/article/view/18192